Skip to content
Screener

Reported August 6, 2026 · After market close

Revenue$11.4MBeat by $1.1M
EPS-$0.16Miss by $0.01
Revenue estimate$10.3M
EPS estimate-$0.16
“We delivered a second quarter marked by year-over-year and strong sequential growth. We continued strengthening our foundation to drive future expansion and adoption of the TriNav platform, and generated clinical evidence that demonstrates and validates the value of our technology. We also wanted to acknowledge the Centers for Medicare and Medicaid Services (.”
Mary Szela

Next report

Date not yet announced

Financials

Q2 2026

Income statement

See full
Revenue$11.4M+1.7%
Gross profit$9.9M+5.2%
Operating income-$9.8M-33.8%
Net income-$9.2M-10.8%
EPS (diluted)-$0.16+40.7%

Balance sheet

See full
Cash & equivalents$46.3M+72.5%
Total debt$33.1M+2.5%
Total equity$6.6M+134%
Total assets$62.4M+51.1%

Cash flow

See full
Operating cash flow-$10.1M-38.4%
CapEx$82.0K—
Free cash flow-$10.2M-41.3%

Valuation & ratios

Valuation

as of 06/30/26
See full
Market cap$279.45M+40.7%
Enterprise value$266.22M+30.5%
P/S6.2×+0.7×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin-67.7%-11.9pp
Net margin-62.6%-13.6pp
FCF margin-51.6%-13.8pp

Returns & leverage

See full
Debt / equity5×—
Current ratio5.3×+1.3×

FAQ

When did TriSalus Life Sciences, Inc. report Q2 2026 earnings?
TriSalus Life Sciences, Inc. (TLSI) reported Q2 2026 earnings on August 6, 2026 after market close.
What were TriSalus Life Sciences, Inc.'s Q2 2026 revenue and EPS?
TriSalus Life Sciences, Inc. reported revenue of $11.4M and eps of $-0.16 for Q2 2026.
Did TriSalus Life Sciences, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $10.3M by $1.1M. EPS missed the consensus estimate of $-0.15 by $0.01.
How did TriSalus Life Sciences, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 1.7% from $11.2M a year earlier and eps grew 40.7% from $-0.27.
Where can I find TriSalus Life Sciences, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-054264) and the 10-Q periodic report (0001628280-26-054275) directly on SEC EDGAR. The filing index links above go to sec.gov.